Tsfg, LLC Sarepta Therapeutics, Inc. Transaction History

Tsfg, LLC

$458 Million
Q3 2024

A detailed history of Tsfg, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Tsfg, LLC holds 50 shares of SRPT stock, worth $6,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 125 60.0%

Holding current value

$6,269

Previous $20,000 70.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$124.33 - $156.75 $9,324 - $11,756	-75 Reduced 60.0%	50 $6,000
Q2 2024 Jul 16, 2024	SELL	$113.33 - $163.85 $3,966 - $5,734	-35 Reduced 21.88%	125 $20,000
Q3 2023 Oct 10, 2023	SELL	$102.5 - $123.59 $9,737 - $11,741	-95 Reduced 37.25%	160 $19,000
Q1 2022 Apr 25, 2022	SELL	$63.15 - $90.42 $8,209 - $11,754	-130 Reduced 33.77%	255 $20,000
Q4 2021 Feb 10, 2022	SELL	$77.28 - $99.42 $2,318 - $2,982	-30 Reduced 7.23%	385 $35,000
Q3 2021 Oct 12, 2021	BUY	$65.97 - $92.48 $1,319 - $1,849	20 Added 5.06%	415 $38,000
Q2 2021 Jul 19, 2021	SELL	$69.38 - $86.75 $72,502 - $90,653	-1,045 Reduced 72.57%	395 $31,000
Q1 2021 Apr 14, 2021	BUY	$72.25 - $168.95 $61,412 - $143,607	850 Added 144.07%	1,440 $107,000
Q4 2020 Jan 20, 2021	SELL	$125.56 - $178.74 $4,394 - $6,255	-35 Reduced 5.6%	590 $101,000
Q3 2020 Oct 06, 2020	BUY	$127.12 - $172.34 $7,627 - $10,340	60 Added 10.62%	625 $88,000
Q2 2020 Jul 07, 2020	SELL	$93.0 - $171.7 $26,505 - $48,934	-285 Reduced 33.53%	565 $91,000
Q1 2020 Apr 08, 2020	BUY	$82.38 - $131.64 $40,366 - $64,503	490 Added 136.11%	850 $83,000
Q4 2019 Jan 27, 2020	SELL	$76.53 - $135.58 $8,035 - $14,235	-105 Reduced 22.58%	360 $46,000
Q3 2019 Jan 27, 2020	BUY	$72.81 - $156.91 $5,824 - $12,552	80 Added 20.78%	465 $35,000
Q2 2019 Jan 27, 2020	SELL	$112.21 - $151.95 $8,415 - $11,396	-75 Reduced 16.3%	385 $59,000
Q1 2019 Jan 27, 2020	BUY	$106.67 - $151.68 $49,068 - $69,772	460 New	460 $55,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account